【个人简历】

2021.9 至今 复旦大学 生物医学研究院 博士生

2013 – 2021    杭州源清生物科技有限公司  

2010 – 2013 法国贡比涅技术大学 生物工程硕士

2007 – 2010 上海大学 生物工程工学学士

【研究方向】

分子标志物用于肿瘤筛查、辅助诊断、用药指导及预后等

【个人邮箱】

21111510044@m.fudan.edu.cn

【发表论文】

1. Wang Q, Hu L, Ma W, Meng Z, Li P, Zhang X, Wang Y, Lu Y, Sun Y, Wu Y, Ren W, Song K, Chen J, et al. UriBLAD - a urine-based gene expression assay for non-invasive detection of bladder cancer[J]. The Journal of Molecular Diagnostics, 2021, 23(1): 61-70.

2. Ye Q, Wang Q, Qi P, Chen J, er al. Development and clinical validation of a 90-gene expression assay for identifying tumor tissue origin[J]. The Journal of Molecular Diagnostics, 2020, 22(9): 1139-1150.

3. Wang Q, Xu M, Sun Y, Chen J, er al. Gene expression profiling for diagnosis of triple-negative breast cancer: a multicenter, retrospective cohort study[J]. Frontiers in Oncology. 2019, 9:354.

4. Wang Q, Gan H, Chen C, Sun Y, Chen J, et al. Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas[J]. Journal of Experimental & Clinical Cancer Research, 2017, 36(1):176.

5. 王奇峰, 徐清华, 陈金影, 钱琛晖, 刘晓健, 杜祥. 一种新型肿瘤组织起源分子标志物的建立与评价[J]. 中国癌症杂志, 2016, 26(10):801-812.

6. Xu Q, Chen J*, Ni S, et al. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin[J]. Modern Pathology, 2016, 29(6): 546-556. (*Co-first author)

7. 陈金影, 蔡虎, 徐清华. 原发灶不明转移癌的临床诊断[J]. 分子诊断与治疗杂志, 2017(1).

8. Dumont A, Pannier D, Ducoulombier A, Tresch E, Chen J, et al. ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors[J]. SpringerPlus, 2015, 4(1):327.

9. Xu Q, Wang Q, Chen J, et al. Identification and validation of a 23-gene expression signature for subtype classification of medulloblastoma.[C]// Annals of Oncology, 29(suppl_8).

10. Pannier D, Dumont A, Tresch E, Chen J, et al. Single nucleotide polymorphisms to predict for neoadjuvant chemotherapy in breast cancer according to estrogen receptor (ER) status.[C]// Meeting of the American-society-of-clinical-oncology. 2013.